How many insider declarations has Lantheus Holdings, Inc. filed?

Lantheus Holdings, Inc. has filed 1 public insider declaration with SEC (Form 4).

What is Lantheus Holdings, Inc.'s role?

Lantheus Holdings, Inc.'s reported role is not specified by the regulator across the filings.

Which companies does Lantheus Holdings, Inc. report trades for?

Lantheus Holdings, Inc. reports trades for Perspective Therapeutics, Inc..

What is Lantheus Holdings, Inc.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 96k€.

← Executives ★ Sign in to follow

LH

Lantheus Holdings, Inc.

·SEC (Form 4)

Perspective Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€96,065

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by Lantheus Holdings, Inc.. Officer active across 1 company, notably Perspective Therapeutics, Inc.. Cumulatively, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €96k. Activity tracked since 1 September 2026. The latest transaction was filed on 1 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Lantheus Holdings, Inc.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Perspective Therapeutics, Inc. (US)

Declarations1 total

▼

Lantheus Holdings, Inc.

10% OwnerExecutives1 Sept 2026Perspective Therapeutics, Inc.

$111,5740SEC ↗

35,769 shares@ US$3.1193Common StockSEC:0002064832-26-000310:0

1 of 1 declaration

InsidersTradesSigma

← Executives ★ Sign in to follow

LH

Lantheus Holdings, Inc.

·SEC (Form 4)

Perspective Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€96,065

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Explore the complete record of transactions filed by Lantheus Holdings, Inc.. Officer active across 1 company, notably Perspective Therapeutics, Inc.. Cumulatively, 1 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €96k. Activity tracked since 1 September 2026. The latest transaction was filed on 1 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.